Literature DB >> 10568890

A pilot study on the antibodies to HHV-6 variants and HHV-7 in CSF of MS patients.

J Ongrádi1, C Rajda, C L Maródi, A Csiszár, L Vecsei.   

Abstract

In the possible role for human herpesviruses (HHV) in the pathogenesis of multiple sclerosis (MS) neither clear distinction between the two variants of HHV-6, nor the involvement of HHV-7 have been described. Therefore, we quantitated HHV-6 variant specific and HHV-7 reacting antibodies in the CSF of 13 patients with MS or other neurological disorders by ELISA. Predominance in the positivity of IgG (67%) and IgM (44%) to HHV-6B over that of IgG (44%) with no detectable IgM to HHV-6A, and no antibodies to HHV-7 were found in the CSF of MS patients. None of these antibodies were found in the CSF of controls. This suggests that, intrathecal chronic active or primary HHV-6B infection might contribute to MS progression, while the local effects of HHV-6A and HHV-7 seem to be less important.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10568890     DOI: 10.3109/13550289909045382

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  10 in total

Review 1.  Human herpesvirus 6 infection as a trigger of multiple sclerosis.

Authors:  Konstantine I Voumvourakis; Dimitrios K Kitsos; Sotirios Tsiodras; George Petrikkos; Eleftherios Stamboulis
Journal:  Mayo Clin Proc       Date:  2010-10-06       Impact factor: 7.616

2.  Gene expression profile of herpesvirus-infected T cells obtained using immunomicroarrays: induction of proinflammatory mechanisms.

Authors:  M Mayne; C Cheadle; S S Soldan; C Cermelli; Y Yamano; N Akhyani; J E Nagel; D D Taub; K G Becker; S Jacobson
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

3.  Intrathecal antibody (IgG) production against human herpesvirus type 6 occurs in about 20% of multiple sclerosis patients and might be linked to a polyspecific B-cell response.

Authors:  Tobias Derfuss; Reinhard Hohlfeld; Edgar Meinl
Journal:  J Neurol       Date:  2005-03-21       Impact factor: 4.849

4.  Use of amplicon-6 vectors derived from human herpesvirus 6 for efficient expression of membrane-associated and -secreted proteins in T cells.

Authors:  Ronen Borenstein; Oded Singer; Adi Moseri; Niza Frenkel
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

5.  Human herpesvirus type 6 indirectly enhances oligodendrocyte cell death.

Authors:  Hong Kong; Quinton Baerbig; Laine Duncan; Nick Shepel; Michael Mayne
Journal:  J Neurovirol       Date:  2003-10       Impact factor: 2.643

6.  Prevalence of human herpesvirus U94/REP antibodies and DNA in Tunisian multiple sclerosis patients.

Authors:  Nadia Ben-Fredj; Walid Ben-Selma; Antonella Rotola; Faten Nefzi; Sabrina Benedetti; Mahbouba Frih-Ayed; Dario Di Luca; Mahjoub Aouni; Elisabetta Caselli
Journal:  J Neurovirol       Date:  2012-11-21       Impact factor: 2.643

Review 7.  Viruses and multiple sclerosis.

Authors:  Jussi Oskari Virtanen; Steve Jacobson
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-08       Impact factor: 4.388

8.  Reactivation of human herpesvirus-6 in natalizumab treated multiple sclerosis patients.

Authors:  Karen Yao; Susan Gagnon; Nahid Akhyani; Elizabeth Williams; Julie Fotheringham; Elliot Frohman; Olaf Stuve; Nancy Monson; Michael K Racke; Steven Jacobson
Journal:  PLoS One       Date:  2008-04-30       Impact factor: 3.240

Review 9.  Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals.

Authors:  Joseph Ongrádi; Dharam V Ablashi; Tetsushi Yoshikawa; Balázs Stercz; Masao Ogata
Journal:  J Neurovirol       Date:  2016-08-18       Impact factor: 2.643

Review 10.  Role of viruses in etiology and pathogenesis of multiple sclerosis.

Authors:  S S Soldan; S Jacobson
Journal:  Adv Virus Res       Date:  2001       Impact factor: 9.937

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.